Vanta Bioscience (BOM:540729) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540729 Vanta Bioscience Ltd BOM:540729
51 GF Score
Price ₹19.64
GF Value ₹11.75
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Vanta Bioscience FFO per Share?

FFO per Share only applies to REITs.

BOM:540729
51GF Score
Vanta Bioscience Ltd BOM:540729
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vanta Bioscience (BOM:540729) Overvalued in 2026?

Based on GuruFocus' analysis, Vanta Bioscience stock appears to be overvalued. The current stock price of ₹19.64 is trading 67.1% above its estimated GF Value™ of ₹11.75. GuruFocus considers Vanta Bioscience to be Significantly Overvalued.

Key valuation signals for BOM:540729:

  • FFO per Share:
  • GF Value™: ₹11.75 vs. price of ₹19.64 (67.1% above fair value)
  • GF Score™: 51/100 with 9 warning signs

No single metric tells the full story. See the BOM:540729 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vanta Bioscience Business Description

Address No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003
Vanta Bioscience Ltd is a full-service preclinical contract research organization based in Chennai, India, providing preclinical safety assessment services for the pharmaceutical, medical devices, nutraceuticals, biotech, agrochemicals, cosmetics, chemical, and feed additive industries. Established as a center of excellence in GLP-compliant toxicology and safety assessment, the company supports clients through toxicology studies, batch release tests, biocompatibility evaluations, agro-chemical and chemical safety assessments, and diet formulation services. It also offers testing and contract research services in clinical and pre-clinical research, biopharma studies, analytical testing, and environmental assessments.
51GF Score

Get the complete analysis for BOM:540729

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹19.64
Price
₹11.75
GF Value